Search

everythinglearnresearchcommunity

for

Search:↓

Most children with rapid hair loss had a known cause, with stress and illness being top triggers, and treatments showed similar improvement.

Telogen effluvium is the most common hair loss in women, often linked to low iron, while tight hairstyles and headscarves increase traction alopecia risk.

A simple method using the wash test and dermatoscopy can help differentiate between two hair loss conditions, androgenetic alopecia and chronic telogen effluvium.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

Anagen effluvium is a reversible condition causing sudden hair loss, often due to chemotherapy or head radiation.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Hair loss causes stress and affects mental health; treatment and support needed.

A 23-year-old man has a benign, non-progressive hair loss patch that doesn't respond to treatment but can be cosmetically treated.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Teloptosis is a key point in hair loss that could help in creating prevention-focused hair care strategies.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

The article explains how to tell apart and treat two common causes of hair loss in women.

People with Telogen Effluvium have similar zinc levels in their blood as healthy individuals.

A woman had temporary hair loss after scalp surgery, which is a rare but self-healing condition that surgeons should recognize to avoid wrong treatment.

COVID-19 may trigger sudden temporary hair loss.

Newborns can experience temporary hair loss in bands, unrelated to sleeping position.

The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.

Certain growth factors significantly affect hair loss in women with telogen effluvium.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.

Accurate diagnosis of hair loss types is crucial for effective treatment.

Hair loss at the site where hair was taken for a transplant can be due to the normal hair growth cycle.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Hair transplant surgery can cause temporary hair loss in the area where hair was taken from.

Effective anesthesia strategies can help minimize hair loss in patients with telogen effluvium during surgery.

CTE can distort results in hair growth trials, so exclude it carefully.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

COVID-19 may cause temporary hair loss due to the body's immune response.